4 ASX All Ords shares up 315% to 682% in a year!

Investors have sent these ASX All Ords shares flying higher. But why?

| More on:
A young woman smiles as she rides a zip line high above the trees.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) has returned a very solid 16.5% over the past 12 months, with four ASX All Ords shares doing plenty of the heavy lifting.

How heavy?

Well, the laggard of the four has gained 315% in a year. Or enough to turn a $6,000 investment into $24,900.

As for the top performer, its gained an eye watering 682%. That would have seen your $6,000 investment grow into $46,920 in just 12 months.

So, which ASX All Ords shares have been shooting the lights out?

I'm glad you asked!

Four top-performing ASX All Ords shares

Starting with the 'laggard', we have gold stock Catalyst Metals Ltd (ASX: CYL).

Twelve months ago, you could have bought this ASX All Ords share for 81 cents. Today those shares are trading for $3.36 apiece. That sees the Catalyst Metals share price up 315% in a year.

One of the catalysts helping drive the Catalyst Metals share price higher has been the soaring gold price. A year ago the yellow metal was trading for US$1,978. The gold price has since soared 38% to be trading at US$2,736 today.

The miner has also benefited from strong production and a recently expanded upgrade of its ore reserve estimate.

As Motley Fool analyst James Mickleboro reported in September:

Catalyst Metal's ore reserves now total 1million ounces of gold. Importantly, it notes that these reserves provide the foundation for its three-year production guidance, which aims to double production from 100,000 ounces to 200,000 ounces.

Which brings us to investigative analytics and intelligence software provider Nuix Ltd (ASX: NXL).

One year ago, the ASX All Ords share was trading for $1.46. At the time of writing today, shares are swapping hands for $7.23 apiece. That puts the Nuix share price up 395% in 12 months.

Nuix has benefited in part from its links to the artificial intelligence (AI) revolution, which could also help revolutionise its future earnings.

As for recent earnings, Nuix reported a 20.9% year on year increase in FY 2024 statutory revenue to $220.6 million. Statutory net profit of $5 million was more than double the prior year.

Moving on to the third high-flying ASX All Ords share, we have another gold stock, Ora Banda Mining Ltd (ASX: OBM).

The Ora Banda share price has risen from 16 cents 12 months ago to 88 cents today. That puts this gold stock up 450% in a year.

In addition to benefiting from a fast-rising gold price, Ora Banda has also grabbed investor interest, with management aiming to double annual gold production from 77,000 ounces to at least 140,000 ounces.

In its September quarterly results, Ora Banda reported a 40% quarter on quarter increase in gold sold to 25,536 ounces, a record for the miner.

And the top performer

Rounding off the list of shares we wish we'd bought 12 months ago (and didn't!) is buy now, pay later (BNPL) stock Zip Co Ltd (ASX: ZIP).

The ASX All Ords share has roared from 38 cents this time last year to $2.97 today for a gain of 682%.

Investors have clearly been pleased with the company's core growth metrics.

In FY 2024, Zip increased its revenue by 28.3% from the prior year to $868 million.

And for the September quarter, on 29 October Zip reported earnings before tax, depreciation and amortisation (EBTDA) of $31.7 million, up 234% year on year.

The ASX All Ords share rocketed 11.8% on the day it released those results.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Zip Co. The Motley Fool Australia has recommended Nuix. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX 200 broke its losing streak to inch higher today.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Consumer Staples & Discretionary Shares

Bapcor shares soar 12% on the appointment of a new CEO

The market’s strong reaction reflects a clear message: investors are ready for a reset.

Read more »

A young woman drinking coffee in a cafe smiles as she checks her phone.
Share Gainers

Why Bapcor, IDP Education, Netwealth, and Ora Banda shares are pushing higher today

These shares are catching the eye with solid gains on Thursday. But why are they rising?

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This ASX stock is going parabolic, and I think it's still a buy

4DMedical shares are up nearly 500% in 2025, but improving revenue visibility suggests the growth story may not be over.

Read more »